SIC 8731 – Commercial Physical and Biological Research
Valuation | |
---|---|
Market Cap ($M) | 587.47 |
Enterprise Value ($M) | 523.02 |
Book Value ($M) | 176.18 |
Book Value / Share | 1.56 |
Price / Book | 3.33 |
NCAV ($M) | 79.46 |
NCAV / Share | 0.70 |
Price / NCAV | 7.39 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.58 |
Return on Assets (ROA) | -0.37 |
Return on Equity (ROE) | -0.44 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.08 |
Current Ratio | 4.08 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 120.58 |
Assets | 217.30 |
Liabilities | 41.12 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 5.72 |
Operating Income | -93.68 |
Net Income | -110.57 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -64.64 |
Cash from Investing | 81.94 |
Cash from Financing | -4.48 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Redmile Group, LLC | 7.40 | 3.12 | |
13G/A | Phoenix Venture Partners II LP | 15.50 | -0.78 | |
13G | McClain Sean | 10.00 | 3.19 | |
13G/A | Fmr Llc | 14.91 | 0.02 | |
13D/A | Casdin Capital, LLC | 4.80 | -19.61 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
96,133 | 303,926 | 31.63 | |
59,836 | 174,420 | 34.31 | |
75,988 | 205,700 | 36.94 | |
(click for more detail) |
Similar Companies | |
---|---|
ICLR – ICON Public Limited Company | INCY – Incyte Corporation |
MEDP – Medpace Holdings, Inc. | MXCT – MaxCyte, Inc. |
NRC – National Research Corporation |
Financial data and stock pages provided by
Fintel.io